Comments

Rein Therapeutics

Q: What sector and industry does Rein Therapeutics (RNTX) operate in?

Rein Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RNTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.20

0.000.00%

At close: -

$2.24

0.041.82%

After Hours: Jan 24, 4:06 PM EDT

Rein Therapeutics (RNTX) Forecast

News Earnings Rein Therapeutics (RNTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Rein Therapeutics (NASDAQ:RNTX) Stock Quotes, Forecast and News Summary

Rein Therapeutics Stock (NASDAQ: RNTX) stock price, news, charts, stock research, profile.

Open	$2.47
Close	$2.20
Volume / Avg.	33.01K / 84.18K
Day Range	$2.15 - $2.47
52 Wk Range	1.84 - 2.65
Market Cap	$48.53M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$2.47
Close	$2.20
Volume / Avg.	33.01K / 84.18K
Day Range	$2.15 - $2.47
52 Wk Range	1.84 - 2.65
Market Cap	$48.53M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rein Therapeutics (RNTX) stock?

You can purchase shares of Rein Therapeutics (NASDAQ:RNTX) through any online brokerage.

View our list of the best stock brokerages

Who are Rein Therapeutics (RNTX) competitors?

Other companies in Rein Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR) and Estrella Immunopharma (NASDAQ:ESLA).

What is the forecast, or price target, for Rein Therapeutics (RNTX) stock?

There is no analysis for Rein Therapeutics to provide a consensus price target.

What is the current price for Rein Therapeutics (RNTX)?

The stock price for Rein Therapeutics (NASDAQ: RNTX) is $2.24 last updated January 24, 2025 at 4:06 PM EST.

Does Rein Therapeutics (RNTX) pay a dividend?

There are no upcoming dividends for Rein Therapeutics.

When is Rein Therapeutics (NASDAQ:RNTX) reporting earnings?

Rein Therapeutics’s Q4 earnings are confirmed for Monday, April 14, 2025.

Is Rein Therapeutics (RNTX) going to split?

There is no upcoming split for Rein Therapeutics.

What sector and industry does Rein Therapeutics (RNTX) operate in?

Rein Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.